Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Ireland Ruling parties disagree on proposal to decriminalise personal drug use ...
  • Brazil Up to 0.3% THC in plants authorised for medical, pharmaceutical, industrial use ...
  • Australia Parliamentary committee makes suggestions for cannabis law in NSW ...
  • Australia Greens announce Parliament will vote on cannabis legalisation this month ...
  • Texas - United States Bills introduced in Senate and House on medical cannabis expansion ...
  • Texas - United States House bill introduced to regulate hemp production and require research permit ...
  • Texas - United States House bills introduced on legalising recreational cannabis ...
  • Lithuania - Ukraine Cannabis conference focuses on fibre hemp, addressing challenges, restrictions ...
  • Czech Republic Criminal law reform approved, will relax some cannabis-related laws ...
  • New Zealand First sublingual THC/CBD spray meets Medicinal Cannabis Agency quality standard ...
  • Poland Motion for cannabis decriminalisation presented to prime minister ...
  • Belgium Health Belgium updates notified herbal products for smoking list ...
View all
Regulatory reports

Belgium: CBD and cannabis regulation, January 2023

Written by || 16th January 2023 || Regulatory reports | Cannabinoids | Cannabis – medical | Cannabis – recreational | Cosmetics | Food | Regulation and legislation | GeographiesBelgium Europe

CBD is not a scheduled substance in Belgium, so its intended use determines whether or not it is legal. CBD in vapour products is currently unregulated in Belgium, but CBD in nicotine-containing vapour products is considered illegal.

Hemp flower legal as long as it contains no more than 0.2% THC. Possession and consumption of cannabis for recreational use is decriminalised. Cannabis cannot be cultivated for medical purposes, but there are some approved cannabis-containing pharmaceuticals made with imported cannabis.

This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes.

Free Sample

Download a free sample page of the report

Belgium: CBD and cannabis regulation, January 2023

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Lorenzo Guaragna

Senior legal analyst
Lorenzo holds a masters degree in International Law from the University of Trento, Italy, where he specialised in aspects of European law. In 2017 he completed a six-month exchange programme with Erasmus+ in Tarragona, Spain. He has had work experience in the legal sector as an intern in a law firm and at the Court of Rovereto, Italy.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.